Global Angiotensin Receptor Antagonists Sales Market Report 2021

Global Angiotensin Receptor Antagonists Sales Market Report 2021

Table of Contents
1 Angiotensin Receptor Antagonists Market Overview
1.1 Angiotensin Receptor Antagonists Product Scope
1.2 Angiotensin Receptor Antagonists Segment by Type
1.2.1 Global Angiotensin Receptor Antagonists Sales by Type (2016 & 2021 & 2027)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Antagonists Segment by Application
1.3.1 Global Angiotensin Receptor Antagonists Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Angiotensin Receptor Antagonists Market Estimates and Forecasts (2016-2027)
1.4.1 Global Angiotensin Receptor Antagonists Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Angiotensin Receptor Antagonists Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Angiotensin Receptor Antagonists Price Trends (2016-2027)
2 Angiotensin Receptor Antagonists Estimates and Forecasts by Region
2.1 Global Angiotensin Receptor Antagonists Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Angiotensin Receptor Antagonists Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Angiotensin Receptor Antagonists Sales Market Share by Region (2016-2021)
2.2.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Region (2016-2021)
2.3 Global Angiotensin Receptor Antagonists Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Angiotensin Receptor Antagonists Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
2.4.2 Europe Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
2.4.3 China Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
2.4.4 Japan Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
2.4.6 India Angiotensin Receptor Antagonists Estimates and Projections (2016-2027)
3 Global Angiotensin Receptor Antagonists Competition Landscape by Players
3.1 Global Top Angiotensin Receptor Antagonists Players by Sales (2016-2021)
3.2 Global Top Angiotensin Receptor Antagonists Players by Revenue (2016-2021)
3.3 Global Angiotensin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Receptor Antagonists as of 2020)
3.4 Global Angiotensin Receptor Antagonists Average Price by Company (2016-2021)
3.5 Manufacturers Angiotensin Receptor Antagonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Angiotensin Receptor Antagonists Market Size by Type
4.1 Global Angiotensin Receptor Antagonists Historic Market Review by Type (2016-2021)
4.1.1 Global Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
4.1.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Type (2016-2021)
4.1.3 Global Angiotensin Receptor Antagonists Price by Type (2016-2021)
4.2 Global Angiotensin Receptor Antagonists Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Angiotensin Receptor Antagonists Sales Forecast by Type (2022-2027)
4.2.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Type (2022-2027)
4.2.3 Global Angiotensin Receptor Antagonists Price Forecast by Type (2022-2027)
5 Global Angiotensin Receptor Antagonists Market Size by Application
5.1 Global Angiotensin Receptor Antagonists Historic Market Review by Application (2016-2021)
5.1.1 Global Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
5.1.2 Global Angiotensin Receptor Antagonists Revenue Market Share by Application (2016-2021)
5.1.3 Global Angiotensin Receptor Antagonists Price by Application (2016-2021)
5.2 Global Angiotensin Receptor Antagonists Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Angiotensin Receptor Antagonists Sales Forecast by Application (2022-2027)
5.2.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Application (2022-2027)
5.2.3 Global Angiotensin Receptor Antagonists Price Forecast by Application (2022-2027)
6 North America Angiotensin Receptor Antagonists Market Facts & Figures
6.1 North America Angiotensin Receptor Antagonists Sales by Company
6.1.1 North America Angiotensin Receptor Antagonists Sales by Company (2016-2021)
6.1.2 North America Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
6.2 North America Angiotensin Receptor Antagonists Sales Breakdown by Type
6.2.1 North America Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
6.2.2 North America Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
6.3 North America Angiotensin Receptor Antagonists Sales Breakdown by Application
6.3.1 North America Angiotensin Receptor Antagonists Sales Breakdown by Application (2016-2021)
6.3.2 North America Angiotensin Receptor Antagonists Sales Breakdown by Application (2022-2027)
7 Europe Angiotensin Receptor Antagonists Market Facts & Figures
7.1 Europe Angiotensin Receptor Antagonists Sales by Company
7.1.1 Europe Angiotensin Receptor Antagonists Sales by Company (2016-2021)
7.1.2 Europe Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
7.2 Europe Angiotensin Receptor Antagonists Sales Breakdown by Type
7.2.1 Europe Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
7.2.2 Europe Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
7.3 Europe Angiotensin Receptor Antagonists Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Angiotensin Receptor Antagonists Market Facts & Figures
8.1 China Angiotensin Receptor Antagonists Sales by Company
8.1.1 China Angiotensin Receptor Antagonists Sales by Company (2016-2021)
8.1.2 China Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
8.2 China Angiotensin Receptor Antagonists Sales Breakdown by Type
8.2.1 China Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
8.2.2 China Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
8.3 China Angiotensin Receptor Antagonists Sales Breakdown by Application
8.3.1 China 156 Sales Breakdown by Application (2016-2021)
8.3.2 China 156 Sales Breakdown by Application (2022-2027)
9 Japan Angiotensin Receptor Antagonists Market Facts & Figures
9.1 Japan Angiotensin Receptor Antagonists Sales by Company
9.1.1 Japan Angiotensin Receptor Antagonists Sales by Company (2016-2021)
9.1.2 Japan Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
9.2 Japan Angiotensin Receptor Antagonists Sales Breakdown by Type
9.2.1 Japan Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
9.2.2 Japan Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
9.3 Japan Angiotensin Receptor Antagonists Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Angiotensin Receptor Antagonists Market Facts & Figures
10.1 Southeast Asia Angiotensin Receptor Antagonists Sales by Company
10.1.1 Southeast Asia Angiotensin Receptor Antagonists Sales by Company (2016-2021)
10.1.2 Southeast Asia Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
10.2 Southeast Asia Angiotensin Receptor Antagonists Sales Breakdown by Type
10.2.1 Southeast Asia Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Angiotensin Receptor Antagonists Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Angiotensin Receptor Antagonists Market Facts & Figures
11.1 India Angiotensin Receptor Antagonists Sales by Company
11.1.1 India Angiotensin Receptor Antagonists Sales by Company (2016-2021)
11.1.2 India Angiotensin Receptor Antagonists Revenue by Company (2016-2021)
11.2 India Angiotensin Receptor Antagonists Sales Breakdown by Type
11.2.1 India Angiotensin Receptor Antagonists Sales Breakdown by Type (2016-2021)
11.2.2 India Angiotensin Receptor Antagonists Sales Breakdown by Type (2022-2027)
11.3 India Angiotensin Receptor Antagonists Sales Breakdown by Application
11.3.1 India Angiotensin Receptor Antagonists Sales Breakdown by Application (2016-2021)
11.3.2 India Angiotensin Receptor Antagonists Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Angiotensin Receptor Antagonists Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Angiotensin Receptor Antagonists Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Angiotensin Receptor Antagonists Products Offered
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Angiotensin Receptor Antagonists Products Offered
12.3.5 Merck Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Business Overview
12.4.3 Astra Zeneca Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astra Zeneca Angiotensin Receptor Antagonists Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Jhonson and Johnson
12.5.1 Jhonson and Johnson Corporation Information
12.5.2 Jhonson and Johnson Business Overview
12.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jhonson and Johnson Angiotensin Receptor Antagonists Products Offered
12.5.5 Jhonson and Johnson Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Business Overview
12.6.3 Eli Lilly Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eli Lilly Angiotensin Receptor Antagonists Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Angiotensin Receptor Antagonists Products Offered
12.7.5 Sanofi Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Corporation Information
12.8.2 Bristol-Myers Squibb Business Overview
12.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bristol-Myers Squibb Angiotensin Receptor Antagonists Products Offered
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer Angiotensin Receptor Antagonists Products Offered
12.9.5 Bayer Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK Angiotensin Receptor Antagonists Products Offered
12.10.5 GSK Recent Development
12.11 Teva Pharmaceutical
12.11.1 Teva Pharmaceutical Corporation Information
12.11.2 Teva Pharmaceutical Business Overview
12.11.3 Teva Pharmaceutical Angiotensin Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Pharmaceutical Angiotensin Receptor Antagonists Products Offered
12.11.5 Teva Pharmaceutical Recent Development
13 Angiotensin Receptor Antagonists Manufacturing Cost Analysis
13.1 Angiotensin Receptor Antagonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Angiotensin Receptor Antagonists
13.4 Angiotensin Receptor Antagonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Angiotensin Receptor Antagonists Distributors List
14.3 Angiotensin Receptor Antagonists Customers
15 Market Dynamics
15.1 Angiotensin Receptor Antagonists Market Trends
15.2 Angiotensin Receptor Antagonists Drivers
15.3 Angiotensin Receptor Antagonists Market Challenges
15.4 Angiotensin Receptor Antagonists Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Angiotensin Receptor Antagonists Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Angiotensin Receptor Antagonists Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Angiotensin Receptor Antagonists Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Angiotensin Receptor Antagonists Sales (K Units) by Region (2016-2021)
Table 5. Global Angiotensin Receptor Antagonists Sales Market Share by Region (2016-2021)
Table 6. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Angiotensin Receptor Antagonists Revenue Share by Region (2016-2021)
Table 8. Global Angiotensin Receptor Antagonists Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Angiotensin Receptor Antagonists Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Angiotensin Receptor Antagonists Revenue Share Forecast by Region (2022-2027)
Table 12. Global Angiotensin Receptor Antagonists Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Angiotensin Receptor Antagonists Sales Share by Company (2016-2021)
Table 14. Global Angiotensin Receptor Antagonists Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Angiotensin Receptor Antagonists Revenue Share by Company (2016-2021)
Table 16. Global Angiotensin Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Antagonists as of 2020)
Table 17. Global Angiotensin Receptor Antagonists Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Angiotensin Receptor Antagonists Manufacturing Sites and Area Served
Table 19. Manufacturers Angiotensin Receptor Antagonists Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Angiotensin Receptor Antagonists Sales (K Units) by Type (2016-2021)
Table 22. Global Angiotensin Receptor Antagonists Sales Share by Type (2016-2021)
Table 23. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Type (2016-2021)
Table 25. Global Angiotensin Receptor Antagonists Sales Share by Type (2022-2027)
Table 26. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Angiotensin Receptor Antagonists Revenue Share by Type (2022-2027)
Table 28. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Type (2022-2027)
Table 29. Global Angiotensin Receptor Antagonists Sales (K Units) by Application (2016-2021)
Table 30. Global Angiotensin Receptor Antagonists Sales Share by Application (2016-2021)
Table 31. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Application (2016-2021)
Table 33. Global Angiotensin Receptor Antagonists Sales (K Units) by Application (2022-2027)
Table 34. Global Angiotensin Receptor Antagonists Sales Share by Application (2022-2027)
Table 35. Global Angiotensin Receptor Antagonists Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Angiotensin Receptor Antagonists Revenue Share by Application (2022-2027)
Table 37. Global Angiotensin Receptor Antagonists Price (USD/Unit) by Application (2022-2027)
Table 38. North America Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 39. North America Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 40. North America Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 42. North America Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 43. North America Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 44. North America Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 45. North America Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 46. North America Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 47. North America Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 48. North America Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 49. North America Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 50. Europe Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 51. Europe Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 52. Europe Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 54. Europe Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 55. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 56. Europe Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 57. Europe Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 58. Europe Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 59. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 60. Europe Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 61. Europe Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 62. China Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 63. China Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 64. China Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 66. China Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 67. China Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 68. China Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 69. China Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 70. China Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 71. China Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 72. China Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 73. China Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 74. Japan Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 75. Japan Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 76. Japan Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 78. Japan Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 79. Japan Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 80. Japan Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 81. Japan Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 82. Japan Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 83. Japan Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 84. Japan Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 85. Japan Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 98. India Angiotensin Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 99. India Angiotensin Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 100. India Angiotensin Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Angiotensin Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 102. India Angiotensin Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 103. India Angiotensin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 104. India Angiotensin Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 105. India Angiotensin Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 106. India Angiotensin Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 107. India Angiotensin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 108. India Angiotensin Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 109. India Angiotensin Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Angiotensin Receptor Antagonists Product
Table 114. Pfizer Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Novartis Angiotensin Receptor Antagonists Product
Table 119. Novartis Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck Angiotensin Receptor Antagonists Product
Table 124. Merck Recent Development
Table 125. Astra Zeneca Corporation Information
Table 126. Astra Zeneca Description and Business Overview
Table 127. Astra Zeneca Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Astra Zeneca Angiotensin Receptor Antagonists Product
Table 129. Astra Zeneca Recent Development
Table 130. Jhonson and Johnson Corporation Information
Table 131. Jhonson and Johnson Description and Business Overview
Table 132. Jhonson and Johnson Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Jhonson and Johnson Angiotensin Receptor Antagonists Product
Table 134. Jhonson and Johnson Recent Development
Table 135. Eli Lilly Corporation Information
Table 136. Eli Lilly Description and Business Overview
Table 137. Eli Lilly Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Eli Lilly Angiotensin Receptor Antagonists Product
Table 139. Eli Lilly Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Sanofi Angiotensin Receptor Antagonists Product
Table 144. Sanofi Recent Development
Table 145. Bristol-Myers Squibb Corporation Information
Table 146. Bristol-Myers Squibb Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bristol-Myers Squibb Description and Business Overview
Table 148. Bristol-Myers Squibb Angiotensin Receptor Antagonists Product
Table 149. Bristol-Myers Squibb Recent Development
Table 150. Bayer Corporation Information
Table 151. Bayer Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Bayer Description and Business Overview
Table 153. Bayer Angiotensin Receptor Antagonists Product
Table 154. Bayer Recent Development
Table 155. GSK Corporation Information
Table 156. GSK Description and Business Overview
Table 157. GSK Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. GSK Angiotensin Receptor Antagonists Product
Table 159. GSK Recent Development
Table 160. Teva Pharmaceutical Corporation Information
Table 161. Teva Pharmaceutical Description and Business Overview
Table 162. Teva Pharmaceutical Angiotensin Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Teva Pharmaceutical Angiotensin Receptor Antagonists Product
Table 164. Teva Pharmaceutical Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Angiotensin Receptor Antagonists Distributors List
Table 168. Angiotensin Receptor Antagonists Customers List
Table 169. Angiotensin Receptor Antagonists Market Trends
Table 170. Angiotensin Receptor Antagonists Market Drivers
Table 171. Angiotensin Receptor Antagonists Market Challenges
Table 172. Angiotensin Receptor Antagonists Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Antagonists Product Picture
Figure 2. Global Angiotensin Receptor Antagonists Sales Market Share by Type in 2021 & 2027
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Antagonists Sales Market Share by Application in 2021 & 2027
Figure 10. Hypertension Examples
Figure 11. Cardiovascular Diseases Examples
Figure 12. Kidney Diseases Examples
Figure 13. Other Examples
Figure 14. Global Angiotensin Receptor Antagonists Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Angiotensin Receptor Antagonists Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Angiotensin Receptor Antagonists Sales (K Units) Growth Rate (2016-2027)
Figure 17. Global Angiotensin Receptor Antagonists Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 18. Global Angiotensin Receptor Antagonists Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Angiotensin Receptor Antagonists Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Angiotensin Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Angiotensin Receptor Antagonists Sales (K Units) Growth Rate (2016-2027)
Figure 22. Europe Angiotensin Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Angiotensin Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Angiotensin Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Angiotensin Receptor Antagonists Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Angiotensin Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Angiotensin Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Angiotensin Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Angiotensin Receptor Antagonists Sales (Million USD) Growth Rate (2016-2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs